Send me real-time posts from this site at my email

Watchlist Update: 11-8-2018 - Immunomedics - IMMU - Analyst Comments

Immunomedics initiated at Jefferies

Immunomedics assumed with a Buy at Jefferies. Jefferies analyst Chris Howerton assumed coverage of Immunomedics with a Buy rating and $30 price target. The analyst says IMU-132 is an active and safe antibody-drug-conjugate "poised to treat multiple tumor types."

Read more at:

(Source theFly)

* This stock has been on our trading list for a while now. Will continue to look for trades in this name. *


Disclosure: I may trade in the ticker symbols mentioned, both long or short. My articles represent my personal opinion and analysis and should not be taken as investment advice. Readers should do their own research before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal.

If you liked this article, please click the LIKE (thumbs up) button.

Feel free to leave any comments, question, or opinions.

Follow us and check back occasionally for additional articles or posts.

Welcome!!! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue